| Market Cap | ₹19,489Cr |
| ROE | 12.09% |
| P/E Ratio(TTM) | 81.15 |
| EPS(TTM) | 187.18 |
| P/B Ratio | 12.04 |
| Dividend Yield | 0.08% |
| Industry P/E | 32.96 |
| Book Value | 1262.09 |
| Debt to Equity | 0.16 |
| Face Value | 10 |
| Parent Organisation | Neuland Laboratories Limited |
| Managing Director | Mr. Davuluri Sucheth Rao |
| Founded | 1984 |
| NSE Symbol | NEULANDLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.31 | ||
| Jubilant Pharmova | NA (0.00%) | 36.09 | ||
| Acutaas Chemicals | NA (0.00%) | 61.77 | ||
| Gujarat Themis Biosyn | NA (0.00%) | 99.88 |